ClinicalTrials.gg
RecruitingNCT06164925Updated Mar 28, 2025

Standardising and Simplifying the Global Leadership Initiative on Malnutrition (GLIM) for Its More General Application

An observational study in Malnutrition, sponsored by University of Tartu. Recruiting at 1 site in Estonia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-03-28.

Sponsored by University of Tartu · Observational

From the registry’s dates

  • Primary completion was expected by Mar 2025, 1 year 7 months ago, but the record still lists the study as recruiting.
  • Started Dec 2023; still recruiting 2 years 10 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Ages
18 Years and older
Sex
All
01

Study summary

This observational study of aims to test whether and how the results of GLIM change when using different approaches and methods to carry out its components.

Read the detailed description

The main questions the study aims to answer are:

  • What is the most effective pre-GLIM screening approach?
  • Which of the simple, globally accessible muscle mass measurement methods works the best in the context of GLIM?
  • How does using simpler approaches to screening and muscle mass measurement affect the performance of GLIM in detecting Subjective Global Assessment (SGA) defined malnutrition and 1-year mortality?

Participants will be/have:

  • asked questions about their recent food intake and possible non-volitional weight loss
  • assessed for malnutrition with SGA
  • weighed, and their height will be measured (if not already recorded)
  • their muscle mass measured with a measuring tape (mid-upper arm circumference and calf circumference) and bioelectrical impedance
  • their muscle function measured using hand grip strength
  • have their patient records looked at to extract their weight and height data (if present), diagnoses, routine blood test results, abdominal computed tomography (CT) scan (if present), dual-energy x-ray absorptiometry (DEXA) scan (if present), 1-year mortality and personal identification code for documentation (the latter will be deleted when the study period is over).
02

Conditions studied

  • Malnutrition

Browse trials for

Keywords

  • GLIM criteria
  • GLIM
  • nutrition assessment
  • nutrition screening
  • muscle mass
03

In context

Malnutrition

1,277 studies on the registry are indexed under Malnutrition; 230 are open to participants now.

This study's planned enrollment of 300 is above the median of 206 across 393 observational studies indexed under Malnutrition.

Browse Malnutrition studies →

Lead sponsor

University of Tartu is the lead sponsor of 46 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Inpatients of day patients admitted to the Tartu University Hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age of 18+ years
  • Able and willing to sign the consent form
  • Inpatients of the Tartu University Hospital
  • Admitted within 72 hours before enrolment

Exclusion criteria

Exclusion Criteria:

  • Age of \<18 years
  • Inability or refusal to sign the consent form
  • Pregnant or lactating women
  • More than 72 hours passed since admission
  • Patients isolating with an infection
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (estimated)
Patient registry
No

Groups and cohorts

  • Inpatients of the Tartu University Hospital

    Inclusion Criteria: Age of 18+ years, able and willing to sign the consent form, inpatients of the Tartu University Hospital, admitted within 72 hours before enrolment. Exclusion Criteria: Age of \<18 years, inability or refusal to sign the consent form, pregnant or lactating women, more than 72 hours passed since admission, patients isolating with an infection.

    Diagnostic Test: Nutrition screening and assessment

Interventions

  • Diagnostic testNutrition screening and assessment

    The patient is interviewed for changes in body weight in the last six months and food intake in the last two weeks. The investigator evaluates the patient's diet, symptoms related to their nutritional status, and functional capacity according to the Subjective Global Assessment (SGA). The SGA tool itself is completed by the researcher. Height and weight of the patient are measured, if not yet recorded, and BMI is calculated. The patient's muscle mass is measured using mid-upper arm circumference (MUAC), calf circumference (CC) and bioelectrical impedance (BIA), and their muscle function assessed using hand grip strength.

06

What researchers measure

Primary outcomes

  1. Subjective Global Assessment (SGA) defined malnutrition

    Subjective Global Assessment (SGA) can be considered a method that is close to a "gold standard" for malnutrition assessment. Therefore, the study will analyse how different approaches to screening and muscle mass measurement affect the performance of GLIM in detecting Subjective Global Assessment (SGA) defined malnutrition.

    Time frame: baseline, pre-intervention/procedure/surgery

  2. One-year mortality

    One year after the data collection, we will look at the patient records to collect the 1-year mortality data. This will give information about whether and how different approaches to components of GLIM affect its ability to predict one-year mortality.

    Time frame: through study completion, an average of 1 year

  3. Computed tomography (CT) defined muscle mass

    One of the GLIM criteria is "reduced muscle mass", and this study will investigate how muscle mass measured with simpler methods compares against muscle mass measured with CT.

    Time frame: baseline, pre-intervention/procedure/surgery

  4. DEXA defined muscle mass

    One of the GLIM criteria is "reduced muscle mass", and this study will investigate how muscle mass measured with simpler methods compares against muscle mass measured with DEXA.

    Time frame: baseline, pre-intervention/procedure/surgery

Secondary outcomes

  1. Bioelectrical impedance (BIA) defined muscle mass

    One of the GLIM criteria is "reduced muscle mass", and this study will investigate how muscle mass measured with simpler methods compares against muscle mass measured with BIA.

    Time frame: baseline, pre-intervention/procedure/surgery

07

Study locations

1 of 1 sites recruiting
  • Tartu Ülikooli Kliinikum
    Tartu, Tartumaa 50406, Estonia
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06164925
Lead sponsor
University of Tartu
Collaborators
Tartu University Hospital
Responsible party
Alastair Forbes (Visiting Professor, University of Tartu) — Principal investigator
First posted
Dec 11, 2023
Start date
Dec 13, 2023
Primary completion
Mar 31, 2025 (estimated)
Completion
Jun 30, 2025 (estimated)
Last update
Mar 28, 2025

Study contacts

Grete Kurik, BSc
Contact
grete.kurik@ut.ee
+372 53436535
Alastair Forbes, MD
Contact
alastair.forbes@ut.ee
Alastair Forbes, MD
principal investigator · University of Tartu, Tartu University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion